HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David L Glaser Selected Research

Myositis Ossificans (Fibrodysplasia Ossificans Progressiva)

9/2009Circulating osteogenic precursor cells in heterotopic bone formation.
3/2009Identification of progenitor cells that contribute to heterotopic skeletogenesis.
3/2009Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1.
5/2008Early diagnosis of fibrodysplasia ossificans progressiva.
2/2008Proximal tibial osteochondromas in patients with fibrodysplasia ossificans progressiva.
2/2007Hematopoietic stem-cell contribution to ectopic skeletogenesis.
5/2006A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva.
3/2004Heterotopic ossification.
12/2003In vivo somatic cell gene transfer of an engineered Noggin mutein prevents BMP4-induced heterotopic ossification.
9/2003Stromal cells of fibrodysplasia ossificans progressiva lesions express smooth muscle lineage markers and the osteogenic transcription factor Runx2/Cbfa-1: clues to a vascular origin of heterotopic ossification?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David L Glaser Research Topics

Disease

10Myositis Ossificans (Fibrodysplasia Ossificans Progressiva)
09/2009 - 09/2003
6Heterotopic Ossification (Ectopic Ossification)
09/2009 - 09/2003
3Inborn Genetic Diseases (Disease, Hereditary)
02/2007 - 09/2003
2Pain (Aches)
10/2017 - 09/2013
1Rotator Cuff Injuries
10/2017
1Obesity
03/2017
1Cardiac Arrhythmias (Arrythmia)
03/2017
1Chronic Obstructive Pulmonary Disease (COPD)
03/2017
1Neoplasms (Cancer)
02/2008
1Osteochondroma (Osteocartilaginous Exostosis)
02/2008
1Aplastic Anemia (Anemia, Hypoplastic)
02/2007
1Disease Progression
02/2007
1Cysts
03/2006
1Inflammation (Inflammations)
01/2006
1Progressive Osseous Heteroplasia
03/2004

Drug/Important Bio-Agent (IBA)

5Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA
03/2009 - 12/2003
2Glycine (Aminoacetic Acid)FDA LinkGeneric
03/2009 - 05/2008
2Type I Bone Morphogenetic Protein ReceptorsIBA
03/2009 - 05/2006
2activin AIBA
03/2009 - 02/2008
2Activin Receptors (Activin Receptor)IBA
03/2009 - 05/2008
2Serine (L-Serine)FDA Link
03/2009 - 05/2008
1Collagen Type I (Type I Collagen)IBA
09/2009
1matrigelIBA
03/2009
1Phosphotransferases (Kinase)IBA
03/2009
1CardiotoxinsIBA
03/2009
1NucleotidesIBA
05/2008
1Codon (Codons)IBA
05/2008
1Activins (Activin)IBA
05/2007
1Interleukin-4 (Interleukin 4)IBA
01/2006
1Interleukin-6 (Interleukin 6)IBA
01/2006
1CytokinesIBA
01/2006
1Bone Morphogenetic Protein 4IBA
03/2004
1Proteins (Proteins, Gene)FDA Link
03/2004
1Adenylyl Cyclases (Adenylyl Cyclase)IBA
03/2004
1GTP-Binding Proteins (G-Protein)IBA
03/2004
1Explosive Agents (Explosives)IBA
09/2003
1Transcription Factors (Transcription Factor)IBA
09/2003

Therapy/Procedure

2Therapeutics
03/2009 - 05/2007
1Tenotomy
10/2017
1Aftercare (After-Treatment)
10/2017
1General Anesthesia
03/2017
1Arthroplasty
09/2013
1Intramuscular Injections
03/2009
1Transplantation
02/2007
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
02/2007
1Decompression
03/2006